A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
Recruiting now
Conditions studied: NAFLD and NASH, NAFLD( Non-alcoholic Fatty Liver Disease ), NAFLD Cirrhosis
In brief
To establish a cohort of elderly fatty liver disease based on the community medical examination population. Through the large-scale cohort study, the risk factors affecting fatty liver in the elderly will be explored in depth from the aspects of lifestyle, environment and genetics, the development pattern and mechanism of fatty liver in the elderly will be analysed, and the health risk assessment system and Chinese standard for fatty liver in the elderly covering cardiovascular risk, risk of hepatic fibrosis and risk of sarcopenia will be established, so as to provide the scientific basis for the precise intervention of fatty liver in the elderly in China.
Key facts
- Study ID
- NCT07241195
- Run by
- The Affiliated Hospital of Hangzhou Normal University
- People needed
- 20000
- Starts
- 2026-03-12
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2026-06-01
Who can join
Age: 65 and older, up to 100. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ① Elderly people aged ≥65 years among permanent residents (living for more than 5 years) in the survey area;
- Imaging diagnosis (ultrasound or FibroScan/FibroTouch) of fatty liver; -③ Voluntary participation in this study and signing an informed consent form.
You may not qualify if…
- ①Major disability, mental illness, major wasting disease, severe cardiac, pulmonary and renal insufficiency;
- Patients with combined primary liver cancer or other types of cancer; -③Patients who have received liver transplant or other organ transplants.
Where it is running
- NO.518 Shangtang Road — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.